Facebook
Twitter
LinkedIn
Forward
MGH Cancer Center Grand Rounds 2024-2025 - Subscription
Massachusetts General Hospital
Cancer Center Grand Rounds 2024-2025
September 19, 2024 - May 22, 2025
Back again the 2024-2025 Cancer Center Grand Rounds are available to the public to attend virtually LIVE via paid subscription.
(Please note: This subscription does not include in-person attendance)
The theme of the series is "Early Detection" and kicks off Thursday September 19, 2024 at 12:00 PM EDT. The series will cover a comprehensive array of disease areas and topics, attendees will be provided with a robust selection of sessions to bring them up to speed on the most cutting-edge research and therapies in oncology.
The subscription will provide access to BOTH the live webinar AND the recording; however, if claiming credit, you may only claim credit for attending one or the other per date.
Target Audience
This activity is intended for research and clinical staff who need to be educated on cutting edge information on advances and perspectives on cancer research and treatment across the full spectrum of cancer specialization.
Learning Objectives
Upon completion of this activity, participants will be able to:
- Evaluate recent advances in early detection research and programs presented in this series
- Assess opportunities to integrate early detection into how you support research
- Assess opportunities to integrate early detection practices & strategies into how you deliver patient care
- Recognize the impact and evolving landscape of early detection in cancer care worldwide
Additional Information
Massachusetts General Hospital Cancer Center and Mass General Brigham
Sessions will be held weekly on Thursday from September 19, 2024 to May 22, 2025 from 12:00 to 1:00 PM.
| Date | Subject | Speaker |
|---|---|---|
September 19, 2024 | Why Should Cancer Centers Develop a Focus on Early Detection? | Moderator: Panelists: Douglas Micalizzi, MD, PhD Erica Warner, ScD Rachel Sisodia, MD |
September 26, 2024 | Infectious Disease MGH, A Global View on Virally-Mediated Cancer Risk, Cervical Cancer | Ruanne Barnabas, MBChB, MSc, DPhil |
October 10, 2024 | “How I Live” Documentary Session | Irini Ablanti, DrPH, MPH, MA |
October 24, 2024 | Town Hall: Health Care in 2024 | Congressman Jake Auchincloss Massachusetts 4th District |
October 31, 2024 | Considering Race and Ancestry When Studying Cancer Risk, Prevention, Early Detection and Treatment | Melissa Davis, PhD Morehouse School of Medicine |
November 7, 2024 | Space Science Program | Catriona Jamieson, MD, PhD University of California San Diego |
November 14, 2024 | Multi-Cancer Detection Assays: Hope or Hype? | Moderator: Jennifer Haas, MD Massachusetts General Hospital
Panelists: Tomasz Beer, MD Exact Sciences
Gil Welch, MD Brigham and Women’s Hospital
Betsy O’Donnell, MD Dana-Farber Cancer Institute |
November 21, 2024 | TBD | Lucy Gilbert, MD, MSc, FRCOG McGill University |
December 12, 2024 | TBD | Ash Alizadeh, MD, PhD Stanford Medicine |
December 19, 2024 | Lung Cancer Screening as an Opportunity for Community Outreach and Engagement | Moderator: Efren Flores, MD Massachusetts General Hospital
Panelists: Chi-Fu Jeffrey Yang, MD Massachusetts General Hospital
Rian Hasson, MD, MPH, FACS Brigham and Women’s Hospital
Michael Gieske, MD St. Elizabeth Healthcare |
Additional dates for the spring schedule will be available soon.
Participation is online streaming – broadcast from Massachusetts General Hospital.
After you register, you will receive an email with details for how to participate.
Colin D. Weekes, MD, PhD - Course Director
Director, Medical Oncology Research for Pancreatic Cancer,
Director, Cancer Center Grand Rounds Program
Massachusetts General Hospital
Douglas Micalizzi, MD, PhD
Clinical Director, Cancer Early Detection and Diagnostics Clinic,
Massachusetts General Hospital Cancer Center
Lecia Sequist, MD, MPH
Program Director, Cancer Early Detection and Diagnostics Clinic,
Massachusetts General Hospital Cancer Center;
Landry Family Professor of Medicine
Harvard Medical School
Accreditation
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AMA PRA Category 1 CreditTM
Mass General Brigham designates this live activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing
Mass General Brigham designates this activity for 1 ANCC contact hour. Nurses should only claim credit commensurate with the extent of their participation in the activity.
Price
| Registration Type | Tuition Price |
|---|---|
| All Registrants | $50.00 |
For questions regarding the registration process, please contact Mass General Brigham Office of Continuing Professional Development at mgbcpd@mgb.org.